Literature DB >> 31600172

Relief of tumor hypoxia unleashes the tumoricidal potential of neutrophils.

Karim Mahiddine1, Adam Blaisdell2, Stephany Ma1, Amandine Créquer-Grandhomme2, Clifford A Lowell1,3,4, Adrian Erlebacher1,3,4,5.   

Abstract

Polymorphonuclear neutrophils (PMNs) are increasingly recognized to influence solid tumor development, but why their effects are so context dependent and even frequently divergent remains poorly understood. Using an autochthonous mouse model of uterine cancer and the administration of respiratory hyperoxia as a means to improve tumor oxygenation, we provide in vivo evidence that hypoxia is a potent determinant of tumor-associated PMN phenotypes and direct PMN-tumor cell interactions. Upon relief of tumor hypoxia, PMNs were recruited less intensely to the tumor-bearing uterus, but the recruited cells much more effectively killed tumor cells, an activity our data moreover suggested was mediated via their production of NADPH oxidase-derived reactive oxygen species and MMP-9. Simultaneously, their ability to promote tumor cell proliferation, which appeared to be mediated via their production of neutrophil elastase, was rendered less effective. Relieving tumor hypoxia thus greatly improved net PMN-dependent tumor control, leading to a massive reduction in tumor burden. Remarkably, this outcome was T cell independent. Together, these findings identify key hypoxia-regulated molecular mechanisms through which PMNs directly induce tumor cell death and proliferation in vivo and suggest that the contrasting properties of PMNs in different tumor settings may in part reflect the effects of hypoxia on direct PMN-tumor cell interactions.

Entities:  

Keywords:  Cancer; Immunology; Neutrophils; Oncology; hypoxia

Year:  2020        PMID: 31600172      PMCID: PMC6934192          DOI: 10.1172/JCI130952

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  63 in total

1.  Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor Cells.

Authors:  Adam Blaisdell; Amandine Crequer; Devin Columbus; Takiko Daikoku; Khush Mittal; Sudhansu K Dey; Adrian Erlebacher
Journal:  Cancer Cell       Date:  2015-12-14       Impact factor: 31.743

2.  MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes.

Authors:  T H Vu; J M Shipley; G Bergers; J E Berger; J A Helms; D Hanahan; S D Shapiro; R M Senior; Z Werb
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

Review 3.  Tumour-associated neutrophils in patients with cancer.

Authors:  Merav E Shaul; Zvi G Fridlender
Journal:  Nat Rev Clin Oncol       Date:  2019-10       Impact factor: 66.675

Review 4.  Hypoxia-inducible factors: key regulators of myeloid cells during inflammation.

Authors:  Nan Lin; M Celeste Simon
Journal:  J Clin Invest       Date:  2016-09-06       Impact factor: 14.808

5.  Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression.

Authors:  Inbal Mishalian; Rachel Bayuh; Liran Levy; Lida Zolotarov; Janna Michaeli; Zvi Gregorio Fridlender
Journal:  Cancer Immunol Immunother       Date:  2013-10-04       Impact factor: 6.968

6.  HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment.

Authors:  Cesar A Corzo; Thomas Condamine; Lily Lu; Matthew J Cotter; Je-In Youn; Pingyan Cheng; Hyun-Il Cho; Esteban Celis; David G Quiceno; Tapan Padhya; Thomas V McCaffrey; Judith C McCaffrey; Dmitry I Gabrilovich
Journal:  J Exp Med       Date:  2010-09-27       Impact factor: 14.307

Review 7.  Endometrial carcinoma.

Authors:  Antonio Di Cristofano; Lora Hedrick Ellenson
Journal:  Annu Rev Pathol       Date:  2007       Impact factor: 23.472

8.  Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy.

Authors:  Priyamvada Jayaprakash; Midan Ai; Arthur Liu; Pratha Budhani; Todd Bartkowiak; Jie Sheng; Casey Ager; Courtney Nicholas; Ashvin R Jaiswal; Yanqiu Sun; Krishna Shah; Sadhana Balasubramanyam; Nan Li; Guocan Wang; Jing Ning; Anna Zal; Tomasz Zal; Michael A Curran
Journal:  J Clin Invest       Date:  2018-10-15       Impact factor: 14.808

9.  Hypoxia selectively inhibits respiratory burst activity and killing of Staphylococcus aureus in human neutrophils.

Authors:  Alison M Condliffe; Edwin R Chilvers; Naomi N McGovern; Andrew S Cowburn; Linsey Porter; Sarah R Walmsley; Charlotte Summers; Alfred A R Thompson; Sadia Anwar; Lisa C Willcocks; Moira K B Whyte
Journal:  J Immunol       Date:  2010-12-06       Impact factor: 5.422

Review 10.  Purinergic Regulation of Neutrophil Function.

Authors:  Xu Wang; Deyu Chen
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

View more
  28 in total

Review 1.  Neutrophils as Orchestrators in Tumor Development and Metastasis Formation.

Authors:  Lydia Kalafati; Ioannis Mitroulis; Panayotis Verginis; Triantafyllos Chavakis; Ioannis Kourtzelis
Journal:  Front Oncol       Date:  2020-12-10       Impact factor: 6.244

Review 2.  Neutrophil diversity and plasticity in tumour progression and therapy.

Authors:  Sebastien Jaillon; Andrea Ponzetta; Diletta Di Mitri; Angela Santoni; Raffaella Bonecchi; Alberto Mantovani
Journal:  Nat Rev Cancer       Date:  2020-07-21       Impact factor: 60.716

Review 3.  Neutrophils in cancer-unresolved questions.

Authors:  Melissa S F Ng; Leonard Tan; Quanbo Wang; Charles R Mackay; Lai Guan Ng
Journal:  Sci China Life Sci       Date:  2021-02-24       Impact factor: 6.038

Review 4.  Metabolic Plasticity of Neutrophils: Relevance to Pathogen Responses and Cancer.

Authors:  Thomas Rogers; Ralph J DeBerardinis
Journal:  Trends Cancer       Date:  2021-05-19

5.  Tumor necrosis: A synergistic consequence of metabolic stress and inflammation.

Authors:  Patricia P Yee; Wei Li
Journal:  Bioessays       Date:  2021-05-16       Impact factor: 4.653

Review 6.  Two-Faced Roles of Tumor-Associated Neutrophils in Cancer Development and Progression.

Authors:  Naofumi Mukaida; So-Ichiro Sasaki; Tomohisa Baba
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

Review 7.  Therapeutic targeting of the hypoxic tumour microenvironment.

Authors:  Dean C Singleton; Andrew Macann; William R Wilson
Journal:  Nat Rev Clin Oncol       Date:  2021-07-29       Impact factor: 66.675

Review 8.  Neutrophils in cancer: heterogeneous and multifaceted.

Authors:  Catherine C Hedrick; Ilaria Malanchi
Journal:  Nat Rev Immunol       Date:  2021-07-06       Impact factor: 53.106

Review 9.  Neutrophil dynamics in the tumor microenvironment.

Authors:  Amanda J McFarlane; Frédéric Fercoq; Seth B Coffelt; Leo M Carlin
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 10.  Tumor-associated myeloid cells: diversity and therapeutic targeting.

Authors:  Alberto Mantovani; Federica Marchesi; Sebastien Jaillon; Cecilia Garlanda; Paola Allavena
Journal:  Cell Mol Immunol       Date:  2021-01-20       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.